『Endocrinology @Point of Care Podcasts』のカバーアート

Endocrinology @Point of Care Podcasts

Endocrinology @Point of Care Podcasts

著者： @Point of Care
無料で聴く

Our @Point of Care Endocrinology Podcasts have healthcare experts discussing and providing information related to endocrinology diagnosis, treatment, management, and other important information.Copyright 2021 At Point of Care, LLC. All rights reserved. 衛生・健康的な生活
エピソード
  • S2E1 - Islet Cell Therapy in T1D

    S2E1 - Islet Cell Therapy in T1D
    2026/06/30

    Join diabetologist, Dr. Anne Peters, and nurse practitioner, Amy Peleckis, as they explore islet cell transplantation for patients with type 1 diabetes. This podcast will focus on appropriate patient selection, available and emerging islet cell therapy options and their clinical trial data, as well as best practices for managing immunosuppression posttransplantation.

    Visit https://suitehome.atpointofcare.com/library/2733.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.
    続きを読む 一部表示
    20 分
  • S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action

    S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action
    2021/05/07
    Visit http://morningcommutepodcast.com/SGLT2inhibitors6 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, Dr. James Januzzi and Dr. Silvio Inzucchi discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They attribute this to cardiologists moving beyond the so-called glucocentric view and focusing on how diabetes therapies might help reduce cardiovascular risk as well. Drs. Januzzi and Inzucchi will also discuss the recent guidelines that now incorporate sodium-glucose cotransporter 2 (SGLT-2) inhibitors into clinical pathways.
    続きを読む 一部表示
    24 分
  • S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

    S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection
    2021/05/07

    Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
    続きを読む 一部表示
    24 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません